About Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 500 articles on the topic as well as attending various medical industry conferences. In 2019 he was listed in the top 100 journalists covering biomedicine and longevity research in the industry report – Top-100 Journalists covering advanced biomedicine and longevity created by the Aging Analytics Agency. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, and, Keep me Prime, and New Economy Magazine. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project. In 2015 he led the Major Mouse Testing Program (MMTP) for the International Longevity Alliance and in 2016 helped the team of the SENS Research Foundation to reach their goal for the OncoSENS campaign for cancer research.
Posts from the author

Scientists at Scripps Research have developed a new screening platform that has allowed them to identify a new set of compounds that appear to have a potent protective effect on the mitochondria of brain cells, helping these cells to defend against the kinds of stresses encountered during Alzheimer’s disease and other neurodegenerative conditions. Improved screening…

According to a new study from Harvard researchers, switching to a healthier lifestyle by the time you reach middle age could potentially give you eight to ten more years of healthy life free from age-related diseases. Healthy habits mean a longer, healthier life This new epidemiological study shows that adopting the five habits of eating…

Everyone is different, and that certainly applies to aging, according to new research that drills down into how people age as individuals rather than looking at population averages.  Everyone ages differently In a new study, researchers at Stanford University School of Medicine have managed to sort people into different categories based on how they are…

You know the story, and it happens to us all eventually: the older we get, the harder our brains find it to learn and remember new things. There are likely to be a myriad of reasons why the brain gets increasingly worse as we age, but these reasons are still poorly understood. Like the old…

Recently LEAF Outreach Director, Elena Milova was featured in an interview over at Medium blog site – Predict. During the interview Elena gives her views on the industry, tells the story of how she became part of the field, and the challenges the industry faces in its quest to develop effective therapies that address the…

There are lots of exciting companies working in the aging field, and it’s a great time to tell you about three of the more interesting ones. Most of these companies are a while away from human trials yet, but their innovations could possibly be truly game changing. Underdog Pharma Underdog Pharmaceuticals is a spin-off company…

Just a quick update to let you know that we are back from the Festive holidays and are working on getting all backer gifts for the MitoMouse project produced and shipped. We had a slight glitch in the system and did not get some of the backers shipping details or sizes so we are currently…

Some pleasant news has recently arrived: Revel Pharmaceuticals has successfully completed a seed round in order to begin developing therapeutics that target glucosepane crosslinks, which are a proposed reason why we age, develop diseases such as diabetes, and suffer from stiffened arteries and hypertension. In the business of startups, a seed round refers to a…

Today, we will take a look at the popular supplement fisetin and see how it stacks up as a geroprotector. History of Fisetin Fisetin is a plant polyphenol and part of the flavonoid group in the flavonol sub-category. The earliest record of isolated fisetin dates back to 1833 from the smoke bush (Rhus cotinus). Its…

New research suggests that senolytic drugs, which remove harmful senescent cells that accumulate during aging, may be an effective therapy for glaucoma, a common age-related condition that leads to loss of vision. In the short term, inflammation serves a useful purpose, as it helps to spur the repair and regeneration of tissue and rallies the…

© 2020 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD